中星集團控股(00055.HK)預計上半年盈利200萬港元-1000萬港元
格隆匯8月13日丨中星集團控股(00055.HK)公佈,集團預期將於截至2021年6月30日止六個月錄得介乎約200萬港元至1000萬港元的溢利,而2020年上半年則錄得虧損約5060萬港元。
董事會認為,該轉變主要歸因於(i)於2021年上半年錄得的持作買賣投資的公平值虧損較2020年上半年減少至約77萬港元(2020年上半年:公平值虧損約3380萬港元);及(ii)於2021年上半年錄得的投資物業公平值收益較2020年上半年增加至約3950萬港元(2020年上半年:公平值收益約54萬港元),其部分被製造及銷售分部的毛利率下降所抵銷,此主要是由於原材料價格於2021年上半年大幅上漲所致。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.